World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines.
World Allergy Organization (WAO) Diagnosis and Rationale for Action against Cow's Milk Allergy (DRACMA) Guidelines.
复制标题
DOI:
10.1097/wox.0b013e3181defeb9
复制
发表时间:
2010-04
期刊:
影响因子:
--
通讯作者:
Vieths S
中科院分区:
文献类型:
--
作者:
Fiocchi A;Brozek J;Schünemann H;Bahna SL;von Berg A;Beyer K;Bozzola M;Bradsher J;Compalati E;Ebisawa M;Guzman MA;Li H;Heine RG;Keith P;Lack G;Landi M;Martelli A;Rancé F;Sampson H;Stein A;Terracciano L;Vieths S
Allergy and clinical immunology societies have issued guidance for the management of food allergy. 1, 2 Guidelines are now regarded as translational research instruments, designed to provide cutting-edge benchmarks for good practice and bedside evidence for clinicians to use in an interactive learning context with their national or international scientific communities. In the management of cow’s milk allergy (CMA), both diagnosis and treatment would benefit from a reappraisal of the more recent literature, for “current” guidelines summarize the achievements of the preceding decade, deal mainly with prevention, 3., 4., 5.–6 do not always agree on recommendations and date back to the turn of the centu-ry. 7, 8 In 2008, the World Allergy Organization (WAO) Special Committee on Food Allergy identified CMA as an area in need of a rationale-based approach, informed by the consensus reached through an expert review of the available clinical evidence, to make inroads against a burdensome, world-wide public health problem. It is in this context that the WAO Diagnosis and Rationale for Action against Cow’s Milk Allergy (DRACMA) Guidelines was planned to provide physicians everywhere with a management tool to deal with CMA from suspicion to treatment. Targeted (and tapped for their expertise), both on the DRACMA panel or as nonsitting reviewers, were allergists, pediatricians (allergists and generalists), gastroenterologists, dermatologists, epidemiologists, methodologists, dieticians, food chemists, and representatives of allergic patient organizations. Ultimately, DRACMA is dedicated to our patients, especially the younger ones, whose burden of issues we hope to relieve through an ongoing and collective effort of more interactive debate and integrated learning.